RPG Life Sciences share news, announcements and annual reports
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
RPG Life Sciences Limited · Face value ₹8 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2008
Last close ₹2,575.70down ₹428.10 (14.25%)BSE ₹2,572.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,003.80.
30 Oct: open ₹2,812.00, high ₹2,849.60, low ₹2,513.50
52-week range of traded prices to 30 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,260 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.93%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,38,78323.6% delivered
RPG Life Sciences board and management
38 filed, newest first.
Aug 2026
15 Aug · Management
15 Aug · Management
Jul 2026
31 Jul · Management
27 Jul · Management
27 Jul · Management
27 Jul · Management
Oct 2025
Jul 2025
Apr 2025
28 Apr · Management
Nov 2024
Sep 2024
24 Sep · Management
Aug 2024
May 2024
8 May · Management
Apr 2024
30 Apr · Management
Feb 2024
1 Feb · Management
Jan 2021
Sep 2019
Nov 2018
Nov 2017
10 Nov · Management
Jun 2016
28 Jun · Management
Oct 2015
Jan 2015
Oct 2014
20 Oct · Management
Board of Directors at their meeting held on October 20, 2014, Ms. Neera Saggi has been appointed as an Additional Director on the Board of the Company.
Sep 2014
30 Sep · Management
Nov 2013
29 Nov · Management
Mr. Ajit Gulabchand has resigned as Director of the Company w.e.f. November 13, 2013. The Board of Directors of the Company has approved the resignation of Mr. Gulabchand by passing Resolution by Circulation on November 28, 2013.
Nov 2011
17 Nov · Management
Mr. Rajesh Shirambekar has been appointed as Head - Legal and Company Secretary and Compliance Officer of the Company with effect from November 11, 2011.
Oct 2011
10 Oct · Management
Mr. Ankur Kumar, Head - Legal & Company Secretary has resigned from the services of the Company w.e.f. October 04, 2011.
Oct 2010
23 Oct · Management
Mr. Sachin Raole, General Manager - Finance has been designated as Chief Financial Officer of the Company.6 Oct · Management
Mr. Niraj Bajaj has resigned as Director of the Company w.e.f. October 1, 2010.
Apr 2010
5 Apr · Management
Mr.Arvind Vasudeva, Managing Director of the company has resigned from the services and he will be relieved on April 09, 2010. Further, Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company with effect from April 09, 2010.
Jan 2009
9 Jan · Management
Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009.
Oct 2008
23 Oct · Management
Board of Directors of the Company at its meeting held today i.e. October 23, 2008, has appointed Mr. Ajit Singh Chouhan as an Additional Director of the Company.